Clinical Roundup Perioperative apalutamide reduces risk of death and metastasis in high-risk localized or locally advanced prostate cancer, study finds November 06, 2026Vol.52 No.41
Clinical Roundup Researchers identify critical window for boosting immunotherapy response in prostate cancer, Roswell Park-led study finds November 06, 2026Vol.52 No.41
Clinical Roundup Routine breast imaging may offer little benefit after double mastectomy for early breast cancer, UCLA-led study finds November 06, 2026Vol.52 No.41
Clinical Roundup Hyperglycemia may reprogram T cells, better controlling tumor growth, preclinical study finds November 06, 2026Vol.52 No.41
Clinical Roundup ASTRO updates guideline on shorter-course radiation therapy for localized prostate cancer October 30, 2026Vol.52 No.40
Clinical Roundup Tarlatamab + durvalumab extend median OS for patients with ES-SCLC, phase III DeLLphi-305 trial finds October 30, 2026Vol.52 No.40
Clinical Roundup Divarasib monotherapy improves OS in previously-treated KRAS G12C-mutated lung cancer, phase III trial finds October 30, 2026Vol.52 No.40
Clinical Roundup Arcotatug tavatecan improves OS and PFS in patients with advanced gastric cancer, phase III study finds October 30, 2026Vol.52 No.40
Clinical Roundup Perioperative Imfinzi + Padcev improves EFS, OS, in MIBC, phase III trial finds October 30, 2026Vol.52 No.40
Clinical Roundup Perioperative apalutamide in high-risk localized or locally advanced prostate cancer substudy supports reduced risk of metastasis and death October 30, 2026Vol.52 No.40